[1]Meng L, Hu S, Huang L, et al.Papillary thyroid cancer coexisting with thyroid tuberculosis: a case report[J]. Oncol Lett, 2014, 7(5):1563-1565.
[2]Yoon SG, Yi JW, Seong CY, et al.Clinical characteristics of papillary thyroid carcinoma arising from the pyramidal lobe[J]. Ann Surg Treat Res, 2017, 92(3):123-128.
[3]Illam SP, Narayanankutty A, Mathew SE, et al. Epithelial mesenchymal transition in cancer progression: preventive Phytochemicals[J]. Recent Pat Anticancer Drug Discov, 2017, 12(3):234-246.
[4]May FE, Westley BR.TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer[J]. Endocr Relat Cancer, 2015, 22(3):465-479.
[5]Li Y, Sun Z, Liu K, et al.Prognostic significance of the co-expression of nucleophosmin and trefoil factor 3 in postoperative gastric cancer patients[J]. Mol Clin Oncol, 2014, 2(6):1055-1061.
[6]Xiao L, Liu YP, Xiao CX, et al.Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers[J]. BMC Clin Pathol, 2014, 14(1):26.
[7]Zhang XJ,Wu JF,Huang J,et al. Expression and clinical significance of trefoil factor 3 in patiens with papillary thyroid carcinoma[J].Acta Anatomica Sinica, 2013(4):503-508. (in Chinese)
张小俊, 吴靖芳, 黄静, 等.三叶因子3在甲状腺乳头状癌中的表达及临床意义[J]. 解剖学报, 2013(4):503-508.
[8]Wu JF. Study on the effect and mechanism of RNA inference targeting TFF3 gene on the proliferation and invasion ability of papillary carcinoma cells[D]. Hebei Medical University, 2016. (in Chinese)
吴靖芳. RNA干扰TFF3基因对人甲状腺乳头状癌细胞增殖与侵袭的影响及机制研究[D]. 河北医科大学, 2016.
[9]You ML, Chen YJ, Chong QY, et al.Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent[J]. Oncotarget, 2017, 8(24):39323-39344.
[10]Khoury T, Chadha K, Javle M, et al.Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma[J]. Int J Gastrointest Cancer, 2005, 35(3):171-177.
[11]Pandey V, Wu ZS, Zhang M, et al.Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma[J]. Breast Cancer Res, 2014, 16(5):429.
[12]Yuan Z, Chen D, Chen X, et al.Overexpression of trefoil factor 3 (TFF3) contributes to the malignant progression in cervical cancer cells[J]. Cancer Cell Int, 2017, 17(1):7.
[13]Hoffmann W.Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution[J]. Cell Mol Life Sci, 2005, 62(24):2932-2938.
[14]Kannan N, Kang J, Kong X, et al.Trefoil factor 3 is oncogenic and mediates antiestrogen resistance in human mammary carcinoma[J]. Neoplasia, 2010, 12(12):1041-1053.
[15]Lamouille S, Xu J, Derynck R.Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014, 15(3):178-196.
[16]Romano S, Staibano S, Greco A, et al.FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential[J]. Cell Death Dis, 2013, 4 (4):e578.
[17]Saxena M, Stephens MA, Pathak H, et al.Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters[J]. Cell Death Dis, 2011, 2 (7):e179.
[18]Zhao XL, Sun T, Che N, et al.Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1[J]. J Cell Mol Med, 2011, 15(3):691-700.
[19]Li S, Lu J, Chen Y, et al.MCP-1-induced ERK/GSK-3beta/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells[J]. Cell Mol Immunol, 2017, 14(7):621-630.
[20]Zhou Q, Chen J, Feng J, et al. SOSTDC1 inhibits follicular thyroid cancer cell proliferation, migration, and EMT via suppressing PI3K/Akt and MAPK/Erk signaling pathways[J]. Mol Cell Biochem, 2017, 435 (1-2):87-95.
[21] Baus-Loncar M, Giraud A. SMultiple regulatory pathways for trefoil factor (TFF) genes[J]. Cell Mol Life Sci, 2005, 62(24):2921-2931.
[22]Lin J, Sun Z, Zhang W, et al.Protective effects of intestinal trefoil factor (ITF) on gastric mucosal epithelium through activation of extracellular signal-regulated kinase 1/2 (ERK1/2)[J]. Mol Cell Biochem, 2015, 404(1-2):263-270.
[23]Xing M.Molecular pathogenesis and mechanisms of thyroid cancer[J]. Nat Rev Cancer, 2013, 13(3):184-199.
|